Cite
CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity.
MLA
UCL - SSS/LDRI - Louvain Drug Research Institute, et al. “CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity.” Clinical Cancer Research, Vol. 19, No.12, p. 3316-3324 (2013), 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130479309&authtype=sso&custid=ns315887.
APA
UCL - SSS/LDRI - Louvain Drug Research Institute, de Graan, A.-J. M., Elens, L., Sprowl, J. A., Sparreboom, A., Friberg, L. E., van der Holt, B., de Raaf, P. J., de Bruijn, P., Engels, F. K., Eskens, F. A. L. M., Wiemer, E. A. C., Verweij, J., Mathijssen, R. H. J., & van Schaik, R. H. N. (2013). CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity. Clinical Cancer Research, Vol. 19, No.12, p. 3316-3324 (2013).
Chicago
UCL - SSS/LDRI - Louvain Drug Research Institute, Anne-Joy M de Graan, Laure Elens, Jason A Sprowl, Alex Sparreboom, Lena E Friberg, Bronno van der Holt, et al. 2013. “CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity.” Clinical Cancer Research, Vol. 19, No.12, p. 3316-3324 (2013). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130479309&authtype=sso&custid=ns315887.